No Data
KPC Pharmaceuticals' 2024 Profit Rises 20%
KPC Group: KPC 2024 Annual Report
KPC Group: Summary of the 2024 Annual Report of KPC
KPC 2024 Annual Report
Summary of the 2024 Annual Report of KPC
KPC Pharmaceuticals, Inc. (600422.SH): In 2024, net income is expected to be 0.648 billion yuan, a year-on-year increase of 19.86%, planning to distribute 3 yuan per share.
GLG reported on March 11 that KPC Pharmaceuticals, Inc. (600422.SH) announced its 2024 annual report, which achieved revenue of 8.401 billion yuan during the reporting period, a year-on-year decrease of 0.34%; net income attributable to the shareholders of the listed company was 0.648 billion yuan, an increase of 19.86% year-on-year; basic EPS was 0.86 yuan. The company plans to distribute a cash dividend of 3.0 yuan (including tax) for every 10 shares to all shareholders.
KPC Pharmaceuticals,Inc (SHSE:600422) Not Lagging Market On Growth Or Pricing
